Literature DB >> 28315438

Rectorite-intercalated nanoparticles for improving controlled release of doxorubicin hydrochloride.

Jian Jin1, Hu Tu2, Jiajia Chen2, Gu Cheng1, Xiaowen Shi2, Hongbing Deng3, Zubing Li4, Yumin Du2.   

Abstract

Controlled release of drugs has been widely researched in biomedical area. Nanoparticles (NPs) as ideal drug carriers are often used to facilitate improvements in the therapeutic index of drugs. In this study, natural polymers carboxymethyl chitosan (CMC) and lysozyme (LY) were mixed to prepare CMC-LY NPs by electrostatic self-assembly interactions. In addition, layered silicate rectorite (REC) was introduced into NPs to explore the effect on the encapsulation efficacy and controlled release of doxorubicin hydrochloride (DOX). It was confirmed that the average size of NPs increased with the addition of REC, and the interlayer distance of REC in NPs was enlarged because of the intercalation with polymer chains. Besides, the encapsulation efficiency and loading capacity of DOX in NPs increased markedly with the accretion of REC. The incorporation of REC into NPs could reduce the initial burst release and prolong the therapeutic time. Such results suggest that the REC-intercalated NPs are promising anticancer drug carriers for efficient cancer therapy.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chitosan; Controlled release; Lysozyme; Nanoparticles; Rectorite

Mesh:

Substances:

Year:  2017        PMID: 28315438     DOI: 10.1016/j.ijbiomac.2017.03.059

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  1 in total

1.  Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.

Authors:  Abdul Hakeem; Fouzia Zahid; Guiting Zhan; Ping Yi; Hai Yang; Lu Gan; Xiangliang Yang
Journal:  Int J Nanomedicine       Date:  2018-02-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.